194 related articles for article (PubMed ID: 12958759)
1. The place of ezetimibe in clinical practice.
Weston C
Hosp Med; 2003 Aug; 64(8):473-8. PubMed ID: 12958759
[TBL] [Abstract][Full Text] [Related]
2. [Ezetimibe--pharmacokinetics and therapeutics].
Araújo RG; Casella Filho A; Chagas AC
Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():20-4. PubMed ID: 16400393
[TBL] [Abstract][Full Text] [Related]
3. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe: a selective cholesterol absorption inhibitor.
Nutescu EA; Shapiro NL
Pharmacotherapy; 2003 Nov; 23(11):1463-74. PubMed ID: 14620392
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe: cholesterol lowering and beyond.
Bays HE; Neff D; Tomassini JE; Tershakovec AM
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.
Bissonnette S; Habib R; Sampalis F; Boukas S; Sampalis JS;
Can J Cardiol; 2006 Oct; 22(12):1035-44. PubMed ID: 17036098
[TBL] [Abstract][Full Text] [Related]
7. Therapy and clinical trials: ezetimibe.
Jialal I; Kappagoda T
Curr Opin Lipidol; 2003 Dec; 14(6):643-6. PubMed ID: 14624143
[No Abstract] [Full Text] [Related]
8. An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care.
Stein EA
Am J Manag Care; 2002 Feb; 8(2 Suppl):S36-9; discussion S45-7. PubMed ID: 11855701
[TBL] [Abstract][Full Text] [Related]
9. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
10. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
Hurley DL; Isley WL
Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
[No Abstract] [Full Text] [Related]
11. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
12. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].
Scheen AJ; Radermecker RP
Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy in cholesterol reduction: focus on ezetimibe and statins.
Grigore L; Norata GD; Catapano AL
Vasc Health Risk Manag; 2008; 4(2):267-78. PubMed ID: 18561502
[TBL] [Abstract][Full Text] [Related]
14. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
Geiss HC; Otto C; Parhofer KG
Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.
Patel SB
Curr Cardiol Rep; 2004 Nov; 6(6):439-42. PubMed ID: 15485605
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe plus simvastatin cardiovascular outcomes study program.
Padial LR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904
[TBL] [Abstract][Full Text] [Related]
17. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.
Jakulj L; Vissers MN; Groen AK; Hutten BA; Lutjohann D; Veltri EP; Kastelein JJ
J Lipid Res; 2010 Apr; 51(4):755-62. PubMed ID: 19828909
[TBL] [Abstract][Full Text] [Related]
18. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?
de Lorgeril M
World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530
[No Abstract] [Full Text] [Related]
19. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
Bruckert E; Giral P; Tellier P
Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
[No Abstract] [Full Text] [Related]
20. Zetia (ezetimibe).
Kloner RA
Congest Heart Fail; 2003; 9(2):109-10. PubMed ID: 12671344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
